Reply to "Anti-TPO antibody, neutrophil, chronic urticaria, and omalizumab"

J Allergy Clin Immunol Pract. 2025 Dec;13(12):3453. doi: 10.1016/j.jaip.2025.09.029.
No abstract available

Publication types

  • Letter